The weight-loss injection Wegovy was launched in the US in 2021 but remains unavailable in most other countries Carsten Snejbjerg/Bloomberg via Getty Images
The weight-loss injection Wegovy is one of the most successful new pharmaceuticals, but many people who want it can’t actually access it.
In most countries in Europe, Wegovy hasn’t yet been launched, despite expected high demand. In the US, one of the few places where it is available, manufacturer Novo Nordisk has been trying to limit the number of people who start taking the medicine.
This isn’t the usual behaviour of a pharmaceutical company with a recently approved medicine expected to generate…
